News
Cardiometabolic risk burden is high in under-50s with type 2 diabetes
- Author:
- Sara Freeman
BARCELONA – Younger people with type 2 diabetes need a more focused treatment strategy, irrespective of cardiometabolic risk.
News
Ketoacidosis is on the rise in children with type 1 diabetes
- Author:
- Sara Freeman
BARCELONA – Data highlight an increase in prevalence at diagnosis, but certain factors may help identify those most at risk.
News
Signs of adult diabetes apparent in very young children
- Author:
- Sara Freeman
BARCELONA – Disturbed HDL cholesterol metabolism may be one of the earliest features of type 2 diabetes.
News
Body weight influences SGLT2-inhibitor effects in type 1 diabetes
- Author:
- Sara Freeman
BARCELONA – Patients with a high body mass index gain the most benefit from sodium-glucose cotransporter 2 inhibitors added to insulin.
News
GABA falls short for type 1 diabetes prevention in children
- Author:
- Sara Freeman
BARCELONA – There was no difference in pancreatic beta-cell function as measured by meal-stimulated C-peptide levels.
News
SUSTAIN 10: Weight loss, glycemic control better with semaglutide than liraglutide
- Author:
- Sara Freeman
BARCELONA – Once-weekly treatment with subcutaneous semaglutide yielded greater reductions in HbA1c and body weight than once-daily...
News
Obesity ups type 2 diabetes risk far more than lifestyle, genetics
- Author:
- Sara Freeman
BARCELONA – Obesity has a dominant effect on the risk of type 2 diabetes over other risk factors, regardless of...
News
Liraglutide ‘option’ for treating pediatric type 2 diabetes
- Author:
- Sara Freeman
BARCELONA – ELLIPSE trial shows clinicians aren’t limited to metformin and insulin for children with diabetes.
News
COMISAIR: CGM ‘makes the difference’ in type 1 diabetes
- Author:
- Sara Freeman
BARCELONA – How patients with type 1 disease monitor their glucose is more important than how insulin is...
News
RISE analyses highlight further youth vs. adult T2D differences
- Author:
- Sara Freeman
BARCELONA – New data delve further into the differences in insulin sensitivity and glucose response in youth and adults with type 2 diabetes.
News
CONCLUDE data inconclusive on hypoglycemia risk for degludec vs. glargine
- Author:
- Sara Freeman
BARCELONA – The primary endpoint of the study was not met, thus differences between the long-acting insulins could not be confirmed.
News
Semaglutide beats canagliflozin as second-line therapy for type 2 diabetes
- Author:
- Sara Freeman
BARCELONA – SUSTAIN 8 trial data show greater reductions in HbA1c and body weight with semaglutide...
News
First data VERIFY value of early combination therapy in type 2 diabetes
- Author:
- Sara Freeman
BARCELONA – Vildagliptin plus metformin provided greater and durable long-term benefits than metformin alone in...
News
Filgotinib fares well in RA trial of inadequate methotrexate responders
- Author:
- Sara Freeman
MADRID – The investigational oral Janus kinase (JAK) 1 inhibitor filgotinib helped more patients achieve an ACR20 response at 12 weeks than did...
News
First adult APS recommendations released by European society
- Author:
- Sara Freeman
MADRID – The EULAR recommendations also cover secondary prevention and management of recurrent episodes and catastrophic APS, for which new...